* Innoviva Inc INVA.OQ INVA.O is expected to show a fall
in
quarterly revenue when it reports results on February 7
(estimated).
* The Burlingame California-based company is expected to
report
a 45.3% decrease in revenue to $58.852 million from $107.68
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Innoviva Inc is for
earnings of 23 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Innoviva
Inc is
$15, above its last closing price of $12.96.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 2.07 2.24 2.80 Beat 24.8
Jun. 30 2022 0.33 1.93 0.05 Missed -97.4
Mar. 31 2022 0.44 0.44 0.35 Missed -20.5
Dec. 31 2021 0.41 0.41 0.14 Missed -65.9
Sep. 0.43 0.90 Beat 109.3
30 2021
Jun. 30 2021 0.29 0.29 0.90 Beat 210.3
Dec. 31 2020 0.40 0.40 0.48 Beat 20
This summary was machine generated February 3 at 11:03 GMT. All
figures in US dollars unless otherwise stated